Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

CNS 5 Thoracic 4 Gastrointestinal 4 Tumor-Agnostic 3 Gynecologic 3 Genitourinary 3 Breast 3 Lymphoid 2 Head & Neck 2 Other hematologic neoplasm 1 NET 1 Myeloid 1 Endocrine 1 Dermatologic 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 6 Magnetic Resonance Spectroscopy 3 Data Collection 3 telotristat ethyl 2 surufatinib 2 Somatostatin 2 Positron-Emission Tomography 2 Everolimus 2 Drug Therapy 2 Biopsy 2 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Quality of Life 1 Plastic Surgery Procedures 1 Phlebotomy 1 Patient Reported Outcome Measures 1 Octreotide 1 Molecular Diagnostic Techniques 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Phlebotomy × NET × Clear all

NCT03130205 2017-08-25

PROGRESS

Uppsala University

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡